Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Oral peptides get digested and typically require specialized formulations to be effective
GH/IGF-1 axis modulation Several Sikiric studies (2010-2020) reported indirect modulation of the GH-IGF-1 axis by BPC-157, with moderate induction of GH receptor expression in scar tissue
DESCRIPTION SECTION DESCRIPTION SECTION Each mL of sterile aqueous solution contains: Active Ingredient: Cyanocobalamin (B 12 )..........1000 mcg Inactive Ingredients: sodium chloride 0.22% w/v, ammonium sulfate 0.1% w/v, citric acid 0.01% w/v, sodium citrate 0.008% w/v, and benzyl alcohol 1.0% v/v (preservative)
By inhibiting this enzyme, 5-Amino-1MQ preserves nicotinamide for NAD+ synthesis, increasing intracellular NAD+ levels through a mechanism entirely distinct from NAD+ precursor supplementation (NMN, NR)
PMID: 39 LawingABleichR
PubMed evidence trail Research sources used to frame this page For BPC-157 Dosage Guide: Protocols & Safety 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
US$ 29.39
US$ 20.60
US$ 28.46
US$ 20.47
